627
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluations

Dasatinib for the treatment of Philadelphia chromosome-positive leukemias

& , MD
Pages 2381-2395 | Published online: 20 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hairong Wang, Yawen Zhang, Xiangle Zeng, Wenjun Pei, Ranran Fan, Yushuai Wang, Xiu Wang & Jianchun Li. (2021) A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy. International Journal of Nanomedicine 16, pages 2373-2388.
Read now

Articles from other publishers (8)

Ilaria Saltarella, Concetta Altamura, Carmen Campanale, Paola Laghetti, Angelo Vacca, Maria Antonia Frassanito & Jean-François Desaphy. (2023) Anti-Angiogenic Activity of Drugs in Multiple Myeloma. Cancers 15:7, pages 1990.
Crossref
Martha Alvarado Ibarra & Jose Antonio De La Peña Celaya. 2019. Geriatric Medicine and Gerontology. Geriatric Medicine and Gerontology.
Toshikatsu Matsui, Kazumasa Miyamoto, Kazunori Yamanaka, Yoshiko Okai, Emily Pfeiffer Kaushik, Kousuke Harada, Matthew Wagoner & Tadahiro Shinozawa. (2019) Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicology and Applied Pharmacology 383, pages 114761.
Crossref
Carole Sourbier, Pei-Jyun Liao, Christopher J. Ricketts, Darmood Wei, Youfeng Yang, Sarah M. Baranes, Benjamin K. Gibbs, Lernik Ohanjanian, L. Spencer Krane, Bradley T. Scroggins, J. Keith Killian, Ming-Hui Wei, Toshiki Kijima, Paul S. Meltzer, Deborah E. Citrin, Len Neckers, Cathy D. Vocke & W. Marston Linehan. (2018) Targeting loss of the Hippo signaling pathway in NF2 -deficient papillary kidney cancers . Oncotarget 9:12, pages 10723-10733.
Crossref
Philippe Rousselot, Marie Magdelaine CoudéNicola GokbugetCarlo Gambacorti PasseriniSandrine HayetteJean-Michel CayuelaFrançoise HuguetThibaut LeguayPatrice ChevallierCelia SalanoubatCaroline BonmatiMagda AlexisMathilde HunaultSylvie GlaisnerPhilippe AgapeChristian BerthouEric JourdanJosé FernandesLaurent SuttonAnne BanosOumedaly RemanBruno LioureXavier ThomasNorbert IfrahMarina Lafage-PochitaloffAnne Bornand, Laure MorissetValérie RobinHeike PfeiferAndre DelannoyJosep RiberaRenato BassanMarc DelordDieter HoelzerHerve Dombret & Oliver G. Ottmann. (2016) Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL. Blood 128:6, pages 774-782.
Crossref
Johanna M. Duyvestyn, Samuel J. Taylor, Samantha A. Dagger & Wallace Y. Langdon. (2016) Dasatinib promotes the activation of quiescent hematopoietic stem cells in mice. Experimental Hematology 44:5, pages 410-421.e5.
Crossref
Michele Modugno. (2014) New resistance mechanisms for small molecule kinase inhibitors of Abl kinase. Drug Discovery Today: Technologies 11, pages 5-10.
Crossref
L. Vargas, A. Hamasy, B. F. Nore & C. I. E. Smith. (2013) Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases. Scandinavian Journal of Immunology 78:2, pages 130-139.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.